The EMA confirmed the cyberattack last week but has not released many details, according to the Dec. 15 report. The agency is working with law enforcement to investigate the incident.
“EMA cannot provide additional details whilst the investigation is ongoing. Further information will be made available in due course,” the European Union agency said in a statement.
Moderna told Reuters that no patient data is at risk of exposure from the attack because it was not included in its submission to the EMA, according to the report.
In the U.S., the FDA’s vaccine advisory committee will meet Dec. 17 to discuss emergency approval of Moderna’s vaccine. The agency authorized Pfizer and BioNTech’s vaccine Dec. 12 for emergency use, the first COVID-19 vaccine to receive approval in the country.
More articles on cybersecurity:
67,000 patient records exposed in California hospital ransomware attack: 5 details
Medtronic releases security update for pacemaker monitors: 4 details
The 5 most significant cyberattacks in healthcare for 2020
